NasdaqCM - Delayed Quote USD
Akebia Therapeutics, Inc. (AKBA)
At close: October 21 at 4:00 PM EDT
Pre-Market: 8:21 AM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 560,000 | 8 |
Sales | 73,856 | 3 |
Net Shares Purchased (Sold) | 486,144 | 11 |
Total Insider Shares Held | 4.57M | -- |
% Net Shares Purchased (Sold) | 11.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
OSTROWSKI ERIK Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 28, 2024 |
ZUMWALT LEANNE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
ROGERS MICHAEL W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
ADAMS ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
GILMAN STEVEN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
WOLF MYLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
FRIESON RON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2024 |
HADAS NICOLE R Officer | Sale at price 1.26 per share. | Direct | 15,140 | May 13, 2024 |
DAHAN MICHEL Chief Operating Officer | Sale at price 1.26 per share. | Direct | 43,898 | May 13, 2024 |
BURKE STEVEN KEITH Officer | Sale at price 1.58 per share. | Direct | 11,327 | Feb 29, 2024 |
BUTLER JOHN P Chief Executive Officer | Sale at price 1.58 per share. | Direct | 73,581 | Feb 29, 2024 |
HADAS NICOLE R Officer | Sale at price 1.58 per share. | Direct | 9,439 | Feb 29, 2024 |
DAHAN MICHEL Chief Operating Officer | Sale at price 1.58 per share. | Direct | 13,684 | Feb 29, 2024 |
BURKE STEVEN KEITH Officer | Sale at price 1.52 per share. | Direct | 12,718 | Feb 27, 2024 |
BUTLER JOHN P Chief Executive Officer | Sale at price 1.52 per share. | Direct | 57,354 | Feb 27, 2024 |
HADAS NICOLE R Officer | Sale at price 1.52 per share. | Direct | 11,265 | Feb 27, 2024 |
DAHAN MICHEL Chief Operating Officer | Sale at price 1.52 per share. | Direct | 16,331 | Feb 27, 2024 |
BURKE STEVEN KEITH Officer | Sale at price 1.68 per share. | Direct | 40,842 | Feb 1, 2024 |
BUTLER JOHN P Chief Executive Officer | Sale at price 1.68 per share. | Direct | 78,102 | Feb 1, 2024 |
BURKE STEVEN KEITH Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
BUTLER JOHN P Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
GRUND NICHOLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
SNOW ELLEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
MALABRE RICHARD C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2024 |
BURKE STEVEN KEITH Officer | Sale at price 1.15 per share. | Direct | 31,050 | Aug 25, 2023 |
SNOW ELLEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jul 31, 2023 |
ZUMWALT LEANNE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
ROGERS MICHAEL W Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
ADAMS ADRIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
GILMAN STEVEN C Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
SMITH CYNTHIA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
WOLF MYLES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
FRIESON RON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 6, 2023 |
HADAS NICOLE R Officer | Sale at price 1.22 per share. | Direct | 77,270 | May 25, 2023 |
DAHAN MICHEL Chief Operating Officer | Sale at price 1.22 per share. | Direct | 116,760 | May 25, 2023 |
HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 24, 2023 |
BURKE STEVEN KEITH Officer | Sale at price 1.07 per share. | Direct | 67,890 | May 16, 2023 |
SPELLMAN DAVID A. Chief Financial Officer | Sale at price 1.07 per share. | Direct | 67,890 | May 16, 2023 |
HADAS NICOLE R Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 12, 2023 |
DAHAN MICHEL Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 12, 2023 |
BURKE STEVEN KEITH Officer | Sale at price 0.88 per share. | Direct | 12,393 | Mar 1, 2023 |
BUTLER JOHN P Chief Executive Officer | Sale at price 0.88 per share. | Direct | 80,614 | Mar 1, 2023 |
HADAS NICOLE R Officer | Sale at price 0.88 per share. | Direct | 11,437 | Mar 1, 2023 |
DAHAN MICHEL Chief Operating Officer | Sale at price 0.88 per share. | Direct | 17,912 | Mar 1, 2023 |
SPELLMAN DAVID A. Chief Financial Officer | Sale at price 0.88 per share. | Direct | 6,327 | Mar 1, 2023 |
Related Tickers
AQST Aquestive Therapeutics, Inc.
4.9500
-1.59%
ESPR Esperion Therapeutics, Inc.
2.0600
+0.98%
ASRT Assertio Holdings, Inc.
1.1500
-0.86%
PTPI Petros Pharmaceuticals, Inc.
0.4174
+30.44%
AVDL Avadel Pharmaceuticals plc
13.42
-1.07%
OPTN OptiNose, Inc.
0.7800
-2.50%
BFRI Biofrontera Inc.
0.9427
+12.23%
SNOA Sonoma Pharmaceuticals, Inc.
2.9700
-6.01%
TLPH Talphera, Inc.
1.0440
-5.09%
SCYX SCYNEXIS, Inc.
1.5200
-5.00%